J
Jabrehoo Med Tech
Genetic technology company based in Beijing
About Jabrehoo Med Tech
Established in June 2011, Beijing Jabrehoo Med Tech Co., Ltd. operates at the intersection of high-throughput gene sequencing, big data, and clinical medical applications, with a specialized focus on reproductive and genetic health. The company was founded by Fei Jia, who serves as the Chairman. Jabrehoo Med Tech provides comprehensive, one-stop solutions for couples undergoing assisted reproduction, individuals facing infertility, and those planning for pregnancy.
The firm's business model is built around an integrated industrial chain that includes technology research and development, product manufacturing, clinical testing services, a proprietary testing database, and the supply of equipment and consumables for assisted reproduction. Its clientele primarily consists of reproductive medicine centers, with its PGT (Preimplantation Genetic Testing) series products covering over 80% of PGD-qualified centers in mainland China. Revenue is generated through the sale of these testing products, which include kits for various genetic screenings, and integrated service platforms that offer solutions for laboratory construction and genetic analysis.
Jabrehoo’s core service portfolio is segmented into prenatal, pre-implantation, and postnatal stages. The company offers a suite of clinical diagnostic products, such as carrier screening for monogenic diseases, tests for infertility-related genetic causes, and non-invasive prenatal testing (NIPT). A key offering is its Preimplantation Genetic Testing (PGT) platform—often associated with third-generation IVF technology—which screens embryos for genetic diseases and chromosomal abnormalities before implantation. The company has processed over 300,000 embryos for PGT-A testing and has established a substantial database for single-gene disease testing, having analyzed over 21,600 pedigrees for more than 1,000 monogenic conditions. To support its clinical partners, Jabrehoo also provides integrated solutions for establishing and certifying assisted reproduction laboratories, including high-throughput sequencing and genetic analysis capabilities.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Aug 2020 | $14M | $57M | Apricot Capital | — |
| SEED✓Equity / VC | Apr 2018 | $0 | — | ShenZhen GTJA Investment Group | — |
Growth signals
Latest recorded traffic for Jabrehoo Med Tech is 290 monthly website visits, up 866.7% over the last three months. Jabrehoo Med Tech's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Jabrehoo Med Tech in the Daxing District ecosystem
The Jabrehoo Med Tech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- SGShenZhen GTJA Investment Group
Series A1 investor entered at this stage
Apricot Capital
Other known investors1 additional known investor
Tengye Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jabrehoo Med Tech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jabrehoo Med Tech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









